Analysis of Alu-mediated genomic deletion in a case with hemeooxygenase-1 deficiency

血红素加氧酶 1 缺陷病例中 Alu 介导的基因组缺失分析

基本信息

  • 批准号:
    13670788
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

To investigate the pathomechanisms of Alu-mediated genomic deletion observed in a case with hemeoxygenase-1 (HO-1) deficiency, following analyses have been performed ;1. Functional analyses of topoisomerase II-binding sites (TBSs) located in the introns and Alu repeats of the human HO-1 gene.The role of Alu-mediated homologous recombination has been established as a pathomechanism in some hereditary diseases and cancers. Since chromosomal double-strand breaks (DSBs) play a crucial role in the homologous recombination processes, potential TBSs found in the introns and Alu repeats, surrounding HO-1 exon 2, could be the target sites of homologous recombination. To test this hypothesis, determination of functional TBSs in the HO-1 gene was performed. HO-1^<+/+> LCLs established from the normal controls were treated with the inhibitors (VP-16 and doxorubicin) of topoisomearase II. The DNA fragments produced by the inhibition of endogenous topoisomerase II resulting in the creation of DSBs w … More ere amplified using a ligation-mediated PCR technique. Several PCR products were determined specifically in the inhibitor-treated LCLs. Sequencing of die products to identify the sites of DSBs are undergoing.2. Functional analyses of the hotspot sequence within the Alu-associated recombination site of the HO-1 gene in the case of HO-1 deficiency.I have found the unique inversion sequences (49 bp) that consist of the conserved 36-bp Alu sequences and Alu core sequences (recombination hotspot) at the deletion site of HO-1 gene. This structural feature showed similarity of the Flp/FRT system (site-specific recombinase system in yeast). To explore a novel site-specific recombinase in the human system, the several synthetic oligonucleotides (49 bp) with sequence variations were designed and used for gel shift assays. In the nuclear extracts derived from human cancer cell lines and a mouse embryonic cell line, NIH3T3, the proteins specifically bound to the probe designated as ATS2.2 that contains the inverted recombination hotspot sequence were identified. I have intended to partially purify these proteins using heparin column chromatography followed by affinity chromatography. The partially purified proteins will be characterized with molecular weight determined by SDS-PAGE and will be analyzed with MALDI-TOF/MS. Less
为探讨血红素加氧酶-1(HO-1)缺乏症患者中观察到的β-内酰胺酶介导的基因组缺失的病理机制,进行了以下分析:1.人HO-1基因内含子和Alu重复序列中拓扑异构酶II结合位点(Topoisomerase II binding sites,TBSs)的功能研究表明,HO-1基因的内含子和Alu重复序列中的TBSs介导的同源重组在某些遗传性疾病和癌症中起重要作用。由于染色体双链断裂(DSB)在同源重组过程中起着至关重要的作用,因此在HO-1外显子2周围的内含子和Alu重复中发现的潜在的TBS可能是同源重组的靶位点。为了检验这一假设,进行了HO-1基因中功能性TBS的测定。用拓扑异构酶II的抑制剂(VP-16和多柔比星)处理从正常对照建立的HO-1^<+/+> LCL。抑制内源性拓扑异构酶II导致DSB产生的DNA片段, ...更多信息 使用连接介导的PCR技术扩增。几个PCR产物被确定具体在走廊处理的LCL。正在对产品进行测序,以确定DSB的位点。HO-1基因缺失时,HO-1基因与Alu相关的重组位点内热点序列的功能分析在HO-1基因缺失位点发现了由保守的36 bp Alu序列和Alu核心序列组成的独特的倒位序列(49 bp)(重组热点)。这一结构特征显示了Flp/FRT系统(酵母中的位点特异性重组酶系统)的相似性。为了探索一种新的位点特异性重组酶在人类系统中,几个合成的寡核苷酸(49 bp)的序列变异的设计和用于凝胶位移测定。在来源于人癌细胞系和小鼠胚胎细胞系NIH 3 T3的核提取物中,鉴定了与包含反向重组热点序列的命名为ATS 2.2的探针特异性结合的蛋白质。我打算用肝素柱层析法和亲和层析法部分纯化这些蛋白质。部分纯化的蛋白质将通过SDS-PAGE测定分子量进行表征,并将使用MALDI-TOF/MS进行分析。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nader G. Abraham: "Human heme oxygenase (HO-1) deficiency and die oxidative injury of vascular endothelial cells"Heme Oxygenase in Biology and Medicine Kluwer Academic/Plenum Publishers. 515 (2002)
Nader G. Abraham:“人血红素加氧酶 (HO-1) 缺乏和血管内皮细胞的氧化损伤”《生物学和医学中的血红素加氧酶 Kluwer 学术/全会出版社》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomoko Toma: "HO-1 production by monocytes as a stress regulator and its clinical relevance"International Journal of Hematology. 73, suppl.. 64 (2001)
Tomoko Toma:“单核细胞产生的 HO-1 作为应激调节剂及其临床相关性”《国际血液学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lijie Yue: "A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity"Pharmacogenetics. Vol.13. 29-38 (2003)
岳丽杰:“人胞苷脱氨酶基因中的功能性单核苷酸多态性有助于ara-C敏感性”药物遗传学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lijie Yue: "Functional analysis of a novel single-nucleotide polymorphism in the human cytidine deaminase gene"Proceedings of American Association for Cancer Research. in press. (2002)
岳丽杰:“人胞苷脱氨酶基因中新型单核苷酸多态性的功能分析”美国癌症研究协会会刊。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lijie Yue: "A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity"Pharmacogenetics. 13. 29-38 (2003)
岳丽杰:“人胞苷脱氨酶基因中的功能性单核苷酸多态性有助于ara-C敏感性”药物遗传学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAIKAWA Yutaka其他文献

SAIKAWA Yutaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAIKAWA Yutaka', 18)}}的其他基金

Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
  • 批准号:
    19K08356
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Computational leukemic stem cell models in systems biology for predicting relapse and development of risk-stratified chemotherapy
系统生物学中用于预测复发和风险分层化疗发展的计算白血病干细胞模型
  • 批准号:
    20591248
  • 财政年份:
    2008
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Kinetic analysis of minimal residual disease using 3-dimentinal computational models of human granulopoiesis and development of risk of relapse-stratified treatment of pediatric leukemia.
使用人类粒细胞生成的三维计算模型对微小残留病进行动力学分析,并制定儿童白血病复发分层治疗的风险。
  • 批准号:
    17591073
  • 财政年份:
    2005
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and cDNA cloning of the transcriptional factors regulating the tissue-specific expression of human alpha-folate receptor gene
调节人α-叶酸受体基因组织特异性表达的转录因子的鉴定及cDNA克隆
  • 批准号:
    09670793
  • 财政年份:
    1997
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Identifying regulatory uORFs as a targetable axis for hereditary disease
识别调节性 uORF 作为遗传性疾病的靶向轴
  • 批准号:
    10709564
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
Identifying regulatory uORFs as a targetable axis for hereditary disease
将调节性 uORF 识别为遗传性疾病的靶向轴
  • 批准号:
    10504131
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
Identifying regulatory uORFs as a targetable axis for hereditary disease
识别调节性 uORF 作为遗传性疾病的靶向轴
  • 批准号:
    10797954
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
Development of contents for building a database for each hereditary disease related to genetic / genomic nursing.
开发与遗传/基因组护理相关的每种遗传性疾病建立数据库的内容。
  • 批准号:
    19K22747
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Development of non-viral vector to realize treatment of hereditary disease using genome editing RNA technology
开发非病毒载体,利用基因组编辑RNA技术实现遗传性疾病的治疗
  • 批准号:
    19K22972
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.
InheRET:一种 SaaS 解决方案,用于识别遗传性疾病风险增加的患者。
  • 批准号:
    10260583
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
InheRET: A SaaS solution to identify patients at increased risk for hereditary disease.
InheRET:一种 SaaS 解决方案,用于识别遗传性疾病风险增加的患者。
  • 批准号:
    10157469
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
Analysis of pathophysiology of skewed X-chromosome inactivation in female patients with X-linked recessive hereditary disease using iPS cells
使用 iPS 细胞分析女性 X 连锁隐性遗传病患者 X 染色体失活的病理生理学
  • 批准号:
    15K09655
  • 财政年份:
    2015
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Splicing Defects in Human Hereditary Disease
人类遗传病中的剪接缺陷
  • 批准号:
    321849
  • 财政年份:
    2015
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Operating Grants
Drug discovery for Familial amyloid polyneuropathy (FAP), an incurable hereditary disease
家族性淀粉样多发性神经病 (FAP) 的药物发现,这是一种无法治愈的遗传性疾病
  • 批准号:
    25253012
  • 财政年份:
    2013
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了